Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices 70561 

requirements of section 3.108(c)(2)(i) of 

the Patient Safety Rule regarding 

notification of providers that have 

reported to the PSO. In addition, 

according to section 3.108(c)(2)(ii) of the 

Patient Safety Rule regarding 

disposition of PSWP, the PSO has 90 

days from the effective date of delisting 

and revocation to complete the 

disposition of PSWP that is currently in 

the PSO’s possession. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/

index.html. 

Dated: November 14, 2013. 

Richard Kronick, 

Director. 

[FR Doc. 2013–28284 Filed 11–25–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: Delisting 

for Cause for Leadership Triad 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of delisting. 

SUMMARY: AHRQ has delisted 

Leadership Triad due to its failure to 

correct a deficiency. The Patient Safety 

and Quality Improvement Act of 2005 

(Patient Safety Act), Public Law 109–41, 

42 U.S.C. 299b–21—b–26, authorizes 

the listing of Patient Safety 

Organizations (PSOs), which are entities 

or component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. HHS issued the Patient Safety 

and Quality Improvement Final Rule 

(Patient Safety Rule) to implement the 

Patient Safety Act. AHRQ administers 

the provisions of the Patient Safety Act 

and Patient Safety Rule relating to the 

listing and operation of PSOs. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on October 4, 2013. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http://

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: pso@

AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act, provides for 

the formation of PSOs, which collect, 

aggregate, and analyze confidential 

information regarding the quality and 

safety of health care delivery. The 

Patient Safety Rule, 42 CFR Part 3, 

authorizes AHRQ, on behalf of the 

Secretary of HHS, to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule. 

Section 3.108(d) of the Patient Safety 

Rule requires AHRQ to provide public 

notice when it removes an organization 

from the list of federally approved 

PSOs. 

In response to a Notice of Proposed 

Revocation and Delisting sent by AHRQ 

pursuant to 42 CFR 3.108(a)(3)(iii)(C), 

Leadership Triad stated that it did not 

meet the requirement that, within 24 

months of initial listing, the PSO must 

have two bona fide contracts with 

different providers for the purpose of 

receiving and reviewing patient safety 

work product. Accordingly, pursuant to 

42 CFR 3.108(a)(5), the notice of 

proposed revocation was affirmed and 

AHRQ revoked the listing of Leadership 

Triad, PSO number P0117, a component 

entity of Triad Health Care LLC, 

effective at 12:00 Midnight ET (2400) on 

October 4, 2013. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/

index.html. 

Dated: November 14, 2013. 

Richard Kronick, 

Director. 

[FR Doc. 2013–28279 Filed 11–25–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–14–0770] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 and 

send comments to LeRoy Richardson, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an email to omb@

cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Proposed Project 

National HIV Behavioral Surveillance 

System (NHBS)—(0920–0770, 

Expiration 05/31/2014)—Extension— 

Center for HIV, Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The purpose of this data collection is 

to monitor behaviors of persons at high 

risk for infection that are related to 

Human Immunodeficiency Virus (HIV) 

transmission and prevention in the 

United States. The primary objectives of 

the NHBS system are to obtain data from 

samples of persons at risk to: (a) 

Describe the prevalence and trends in 

risk behaviors; (b) describe the 

prevalence of and trends in HIV testing 

and HIV infection; (c) describe the 

prevalence of and trends in use of HIV 

prevention services; (d) identify met and 

unmet needs for HIV prevention 

services in order to inform health 

departments, community based 

organizations, community planning 

groups and other stakeholders. 

By describing and monitoring the HIV 

risk behaviors, HIV seroprevalence and 

incidence, and HIV prevention 

experiences of persons at highest risk 

for HIV infection, NHBS provides an 

important data source for evaluating 

progress towards national public health 


emcdonald on DSK67QTVN1PROD with NOTICES